Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Brendon P. Boot
Based on 7 articles published since 2010
(Why 7 articles?)
||||
Expertise Level
The expertise of Brendon P. Boot ranks in the
  • Top 3.5%
  • ... of 91,190 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Aliases Boot, Brendon   ·   Boot, Brendon P
Work Locations
Details
Probable:    Harvard University Boston   Contact    
2017
  • Department of Neurology, Mayo Clinic, Rochester, MN, USA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA. · Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, AZ, USA. · Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA. · Department of Neurology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. · Center for Sleep Medicine, Mayo Clinic, Rochester, MN, USA. · Pubmed 28649596
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
2016
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
Probable:    Mayo Clinic Rochester      
2013
  • Department of Neurology, Mayo Clinic College of Medicine, Rochester MN, Scottsdale, AZ, USA. · Pubmed 23892702
2012
  • Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. · Pubmed 22275251
2012
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Pubmed 22366793
Probable:    Mayo Clinic Scottsdale      
2013
  • Department of Neurology, Mayo Clinic College of Medicine, Rochester MN, Scottsdale, AZ, USA. · Pubmed 23892702
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Brendon P. Boot in 2010-2020 about Parkinson Disease:

  • Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease. 2019
  • Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample. 2017
  • Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. 2017
  • Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. 2016
  • Risk factors for dementia with Lewy bodies: a case-control study. 2013
  • Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. 2012
  • Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. 2012
Show List of Full Article Records
Google Searches

Learn more about Brendon P. Boot using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Mayo Clinic Rochester
Mayo Clinic Scottsdale
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Unspecified
2019
  • Department of Neurology, University of California, San Francisco. · Department of Neurological Surgery, University of California, San Francisco. · Department of Neurology, University of Pittsburgh. · Department of Neurological Surgery, University of Pittsburgh. · Voyager Therapeutics, Inc. · Department of Radiology and Biomedical Imaging, University of California, San Francisco. · Department of Neurology, Oregon Health Sciences University. · Pubmed 30802998
Harvard University Boston
2017
  • Department of Neurology, Mayo Clinic, Rochester, MN, USA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA. · Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, AZ, USA. · Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA. · Department of Neurology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. · Center for Sleep Medicine, Mayo Clinic, Rochester, MN, USA. · Pubmed 28649596
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
2016
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
Mayo Clinic Rochester
2013
  • Department of Neurology, Mayo Clinic College of Medicine, Rochester MN, Scottsdale, AZ, USA. · Pubmed 23892702
2012
  • Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. · Pubmed 22275251
2012
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Pubmed 22366793
Mayo Clinic Scottsdale
2013
  • Department of Neurology, Mayo Clinic College of Medicine, Rochester MN, Scottsdale, AZ, USA. · Pubmed 23892702
Yearly article counts 01021001200
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.